Loan Note: The Rise of the Zombie Funds; Record Year for Emerging Market Private Credit

Why It Matters

Growing zombie fund activity and record emerging‑market credit deployments reshape capital allocation, raising both yield potential and systemic risk for investors.

Key Takeaways

• Zombie funds proliferate, chasing low‑yield opportunities
• Emerging market private credit hit record deployment in 2023
• New Spain‑focused fund targets distressed corporate loans
• Investor appetite shifts toward higher‑yield, risk‑adjusted assets
• Regulatory scrutiny intensifies on illiquid fund structures

Pulse Analysis

The proliferation of "zombie" funds reflects a broader industry adaptation to a low‑interest‑rate environment. These vehicles, often characterized by aging portfolios and limited liquidity, persist by targeting niche, low‑yield assets that traditional funds avoid. While they can provide steady cash flows, their extended lifespans raise concerns about capital efficiency and potential mismatches between investor expectations and fund performance.

Emerging‑market private credit experienced a landmark year, with deployment volumes surpassing previous records. Drivers include robust demand for higher yields, limited sovereign financing options, and a growing appetite among institutional investors for diversified credit exposure. This influx of capital has accelerated deal flow in regions such as Latin America and Southeast Asia, prompting lenders to refine risk‑assessment frameworks and deepen local partnerships to navigate political and currency volatility.

The upcoming Spain‑focused fund exemplifies a strategic pivot toward distressed corporate lending in a market poised for recovery. By leveraging local expertise and targeting under‑performing assets, the fund aims to capture upside while mitigating downside through active restructuring. This move underscores a broader trend where fund managers seek differentiated opportunities in mature European economies, balancing higher return potential against heightened regulatory scrutiny and the need for transparent governance.